5 months on Spiro and 6 weeks on oral Monoxidil. Beyond thrilled with the results so far
    Female 3/3/2020

    From the encyclopedia
    Spironolactone →

    powerful topical and oral anti-androgen used mostly by women

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Spironolactone (oral) 100mg 5 months
    💊 Minoxidil (oral) 0.9mg 6 weeks
    the tone is 😀 positive with impressive results.

    Other terms

    Treatments for hair loss, specifically the use of Spironolactone (Spiro) and oral Minoxidil, as well as Finasteride and RU58841.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

      community Female 37/F - On Meds, but no progress. Add PRP?

       4 upvotes 3 years ago
      A 37-year-old woman with androgenetic alopecia is using spironolactone, oral and topical minoxidil, and considering PRP therapy due to lack of progress. She is unable to obtain finasteride, dutasteride, or bicalutamide and is exploring other options like Clascoterone and RU58841.

      community *WOMEN* on Spironolactone - experiences?

       6 upvotes 10 years ago
      Hair loss treatments discussed: Minoxidil, Finasteride, RU58841, and Spironolactone. Woman with androgenetic alopecia and alopecia areata shares experience using Spironolactone.

      community Having AGA as a girl makes me depressed

       65 upvotes 7 months ago
      A 20-year-old woman with androgenetic alopecia feels depressed about her hair loss, despite using topical minoxidil, spironolactone, and saw palmetto. Suggestions include trying oral minoxidil, higher doses of finasteride or dutasteride, and checking for vitamin deficiencies and heavy metal exposure.

      community 24 y/o woman diagnosed with AGA today. Scared and confused.

       8 upvotes 10 years ago
      A 24-year-old woman being diagnosed with androgenic alopecia (AGA) who is scared and confused about her hair loss, and the treatment options of Minoxidil, finasteride, RU58841, spironolactone, and possibly a biopsy.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 4 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

    Related Research

    6 / 6 results
      Clinical Updates in Hair

      research CLINICAL UPDATES IN HAIR

      19 citations , January 1997 in “Dermatologic Clinics”
      This chapter reviews various antiandrogens and androgen inhibitors, detailing their mechanisms, uses, and side effects, with a focus on spironolactone, finasteride, dutasteride, and oral contraceptives.
      Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      research Antiandrogens and Androgen Inhibitors

      November 2020 in “Elsevier eBooks”
      This source outlines various antiandrogen and androgen inhibitor drugs used to treat cutaneous disorders of hyperandrogenism, detailing their mechanisms, uses, dosages, and side effects, with emphasis on spironolactone, finasteride, dutasteride, and oral contraceptives.
      Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment

      research Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment

      August 2025 in “Drug Design Development and Therapy”
      This review article examines current drugs for androgenetic alopecia, focusing on their mechanisms and clinical efficacy, noting that while finasteride and minoxidil are commonly approved treatments, new drugs targeting different pathogenic pathways have emerged, offering a broader understanding and reference for AGA treatment options.
      Compounding as a Current Therapeutic Option in Dermatology

      research Compounding as a Current Therapeutic Option in Dermatology

      1 citations , October 2013 in “Actas Dermo-Sifiliográficas”
      This review discusses the current role and challenges of compounding in dermatology without presenting new research results; the authors suggest its resurgence in practice despite pharmaceutical alternatives.